SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Rat dog micro-cap picks...

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: BW3/17/2005 9:50:17 AM
  Read Replies (1) of 48461
 
TGEN - major skunking from this news. I haven't followed them closely much, how major is this or do we have a sweet rat buy here?

Targeted Genetics cystic fibrosis drug fails trial
Thu Mar 17, 2005 09:22 AM ET
NEW YORK, March 17 (Reuters) - Targeted Genetics Corp. (TGEN.O: Quote, Profile, Research) on Thursday said its experimental treatment for cystic fibrosis failed to meet the primary goal of a mid-stage trial, and that the company will no longer study the medicine.

The Seattle-based company scrapped its development program for the medicine, called tgAAVCF, after it failed to improve lung function, compared to placebo, in a Phase II trial among patients with mild to moderate cystic fibrosis. The disease, caused by a faulty gene, causes dangerous amounts of mucous to build up in the lungs, which can become infected.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext